IRIS
BARTOLETTI, MICHELE
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
NA - Nord America 1.263
EU - Europa 190
AS - Asia 75
AF - Africa 10
Continente sconosciuto - Info sul continente non disponibili 1
Totale 1.539
Salva come PNG Salva come JPEG
Nazione #
US - Stati Uniti d'America 1.260
IT - Italia 57
UA - Ucraina 39
CN - Cina 37
IE - Irlanda 27
SE - Svezia 20
VN - Vietnam 19
DE - Germania 17
BE - Belgio 11
EG - Egitto 9
GB - Regno Unito 9
TR - Turchia 9
IN - India 6
FI - Finlandia 5
CA - Canada 3
AE - Emirati Arabi Uniti 2
IR - Iran 2
RU - Federazione Russa 2
CZ - Repubblica Ceca 1
EU - Europa 1
NO - Norvegia 1
RO - Romania 1
TG - Togo 1
Totale 1.539
Salva come PNG Salva come JPEG
Città #
Chandler 193
Fairfield 132
Woodbridge 110
Ann Arbor 91
Ashburn 90
Seattle 63
Houston 60
Wilmington 51
Cambridge 44
Princeton 27
Dublin 25
Beijing 23
Dearborn 23
New York 22
Dong Ket 19
Jacksonville 18
Redmond 16
Brussels 11
Izmir 9
Martignacco 9
Ogden 8
San Diego 7
Washington 6
Des Moines 5
Andover 4
Boardman 4
Falls Church 4
Leawood 4
Los Angeles 4
San Mateo 4
Udine 4
Zoppola 4
Al Qahirah al Jadidah 3
Augusta 3
Jinan 3
Nanjing 3
Scafati 3
Toronto 3
Abu Dhabi 2
Ardabil 2
Cairo 2
Edinburgh 2
Norwalk 2
Novara 2
Philadelphia 2
Phoenix 2
Shanghai 2
Venice 2
Asti 1
Bangalore 1
Boydton 1
Codroipo 1
Fuzhou 1
Hefei 1
Kunming 1
Langfang 1
Lomé 1
Melfi 1
Mortegliano 1
Nanchang 1
Naples 1
New Delhi 1
Prague 1
Redwood City 1
Romans 1
Rutigliano 1
San Remo 1
Trento 1
Tuenno 1
Wenzhou 1
Totale 1.154
Salva come PNG Salva come JPEG
Nome #
Risk factors for carbapenem-resistant Klebsiella pneumoniae bloodstream infection among rectal carriers: A prospective observational multicentre study 152
Infections caused by KPC-producing Klebsiella pneumoniae: Differences in therapy and mortality in a multicentre study 140
Risk factors for bloodstream infections due to colistin-resistant KPC-producing Klebsiella pneumoniae: results from a multicenter case-control-control study 119
Predictive models for identification of hospitalized patients harboring KPC-producing klebsiella pneumoniae 118
The SLICE study: The prognostic role of visceral fat in metastatic colorectal cancer 117
Lactate Dehydrogenase (LDH) Response to First-Line Treatment Predicts Survival in Metastatic Breast Cancer: First Clues for A Cost-Effective and Dynamic Biomarker 99
Mucosal Injury during Anti-Cancer Treatment: From Pathobiology to Bedside 84
A risk score integrating lymphocytes ratios (LRs) and lactate dehydrogenase (LDH) levels to predict prognosis in metastatic breast cancer (MBC) patients 77
A TGF-β associated genetic score to define prognosis and platinum sensitivity in advanced epithelial ovarian cancer 74
Monitoring metastatic breast cancer (M-MBC) during treatment: a GIM (Gruppo Italiano Mammella) survey 67
Neutrophil-to-lymphocyte ratio in metastatic breast cancer patients: relationship with tumor characteristics and survival 63
Small luminal-like breast cancer: determinants of adjuvant chemotherapy use 60
Bevacizumab or PARP-Inhibitors maintenance therapy for platinum-sensitive recurrent ovarian cancer: A network meta-analysis 52
Biologically driven cut-off definition of lymphocyte ratios in metastatic breast cancer and association with exosomal subpopulations and prognosis 38
Lactate dehydrogenase as a prognostic biomarker in patients with hormone receptor-positive metastatic breast cancer treated with palbociclib: An exploratory cohort study 37
Platinum-Based Chemotherapy in Older Patients with Non-Small Cell Lung Cancer: What to Expect in the Real World 32
A fully virtual and nationwide molecular tumor board for gynecologic cancer patients: The virtual experience of the MITO cooperative group 31
Prognostic role of visceral fat for overall survival in metastatic colorectal cancer: A pilot study 30
Clinico-radiological monitoring strategies in patients with metastatic breast cancer: a real-world study 28
Tocilizumab in patients with severe COVID-19: a retrospective cohort study 28
Cytoreductive surgery followed by chemotherapy and olaparib maintenance in BRCA 1/2 mutated recurrent ovarian cancer: A retrospective MITO group study 27
Managing COVID-19 in the oncology clinic and avoiding the distraction effect 26
Human epidermal growth factor receptor-2 (HER2) is a potential therapeutic target in extramammary Paget's disease of the vulva 25
Emerging molecular alterations leading to histology-specific targeted therapies in ovarian cancer beyond PARP inhibitors 22
Association of ADME gene polymorphisms on toxicity to CDK4/6 inhibitors in patients with HR+ HER2- metastatic breast cancer 19
Self-Therapeutic Cobalt Hydroxide Nanosheets (Co(OH)2NS) for Ovarian Cancer Therapy 18
AKT Isoforms Interplay in High-Grade Serous Ovarian Cancer Prognosis and Characterization 17
An Exceptional Response to Dostarlimab in Mismatch Repair Deficient, Microsatellite Instability-High and Platinum Refractory Endometrial Cancer 14
The Role of Obesity in Early and Long-Term Outcomes after Surgical Excision of Lung Oligometastases from Colorectal Cancer 13
LC-MS/MS Method for the Quantification of PARP Inhibitors Olaparib, Rucaparib and Niraparib in Human Plasma and Dried Blood Spot: Development, Validation and Clinical Validation for Therapeutic Drug Monitoring 6
Number Needed to Treat in Trials of Targeted Therapies for Advanced Ovarian Cancer 5
Incorporation of anti-PD1 or anti PD-L1 agents to platinum-based chemotherapy for the primary treatment of advanced or recurrent endometrial cancer. A meta-analysis 3
Totale 1.641
Salva come PNG Salva come JPEG
Categoria #
all - tutte 6.423
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 6.423
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2018/201952 0 0 0 0 0 0 0 0 0 10 27 15
2019/2020325 9 8 9 34 23 42 37 42 48 34 23 16
2020/2021346 14 31 50 43 18 19 14 40 18 22 36 41
2021/2022256 20 17 6 7 9 7 16 8 1 38 95 32
2022/2023381 32 42 9 50 42 83 1 37 61 3 11 10
2023/2024165 19 16 15 9 31 44 0 10 12 9 0 0
Totale 1.641